4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-22-011438
President & CEO sold 12,480 shares at $10.95 ($136,656)
From the SEC's structured data for this filing
Trades in this filing
ROBIN HOWARD W · President & CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-16 | Sale : show line 1 in the form | −12,480 | $10.95 | $136,656 | 589,020 | D |
| Open-market sales · 12,480 sh · avg $10.95 · $136,656 | ||||||
Loading xslF345X03/doc4.xml…